Synthesis and Structure-Activity relationship of 1-(5-isoquinolinesulfonyl)piperazine analogues as inhibitors of Mycobacterium tuberculosis IMPDH. (2019)
Attributed to:
Newton001 Understanding Antimicrobial Resistance Mutations in Tuberculosis: Towards Personalised Treatment to Combat Multi-drug Resistance
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejmech.2019.04.027
PubMed Identifier: 31055147
Publication URI: http://europepmc.org/abstract/MED/31055147
Type: Journal Article/Review
Volume: 174
Parent Publication: European journal of medicinal chemistry
ISSN: 0223-5234